Inventor · disambiguated record
Siler Panowski
Also filed as: PANOWSKI SILER
10 granted patents·10 pending applications·20 citations·filing 2008–2024
83Inventor score
Top patents by PatentIndex Score
20 records- 0193US11673953B2DLL3 targeting chimeric antigen receptors and binding agentsALLOGENE THERAPEUTICS INC·Filed 2020·Granted Jun 13, 2023·9 cites·31 claims
- 0292US11377500B2Antibodies specific for CD70 and their usesPFIZER·Filed 2019·Granted Jul 5, 2022·8 cites·36 claims
- 0385US11396551B2Chimeric antigen receptors targeting CD70PFIZER·Filed 2019·Granted Jul 26, 2022·2 cites·47 claims
- 0479US12036243B2BCMA CAR-T cells with enhanced activitiesALLOGENE THERAPEUTICS INC·Filed 2021·Granted Jul 16, 2024·1 cites·32 claims
- 0578US2025145725A1Chimeric antigen receptors targeting cd70PFIZER·Filed 2024·Application pending·0 cites
- 0678US2025011446A1Antibodies specific for cd70 and their usesPFIZER·Filed 2024·Application pending·0 cites
- 0775US12152081B2Chimeric antigen receptors targeting CD70PFIZER·Filed 2022·Granted Nov 26, 2024·0 cites·42 claims
- 0875US11987634B2Antibodies specific for CD70 and their usesPFIZER·Filed 2022·Granted May 21, 2024·0 cites·33 claims
- 0975US2025230410A1Chimeric antigen receptors with enhanced signaling and activities and uses thereofALLOGENE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1072US2025051421A1Constitutively active chimeric cytokine receptorsALLOGENE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1170US2024016846A1Chimeric cytokine receptors bearing a pd-1 ectodomainALLOGENE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1268US12215347B2Chimeric antigen receptors with enhanced signaling and activities and uses thereofALLOGENE THERAPEUTICS INC·Filed 2021·Granted Feb 4, 2025·0 cites·12 claims
- 1363US2024228639A1Cd70 anti-idiotype antibodiesALLOGENE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1462US2024216430A1Claudin 18.2 targeting chimeric antigen receptors and binding agents and uses thereofALLOGENE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1561US12404315B2Protease-activating CD45-gate CARALLOGENE THERAPEUTICS INC·Filed 2021·Granted Sep 2, 2025·0 cites·35 claims
- 1661US12043655B2Constitutively active chimeric cytokine receptorsALLOGENE THERAPEUTICS INC·Filed 2020·Granted Jul 23, 2024·0 cites·39 claims
- 1761US11786553B2Chimeric cytokine receptors bearing a PD-1 ectodomainALLOGENE THERAPEUTICS INC·Filed 2020·Granted Oct 17, 2023·0 cites·33 claims
- 1860US2022409665A1Selective targeting of host cd70+ alloreactive cells to prolong allogeneic car t cell persistenceALLOGENE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1959US2023346934A1Chimeric switch receptors for the conversion of immunesuppressive signals to costimulatory signalsALLOGENE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2052US2009092551A1Increasing lifespan by modulation of pha-4SALK INST FOR BIOLOGICAL STUDI·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Siler Panowski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →